Search Results - "SAKAI, KAZUKO" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

by Yonesaka, Kimio, Haratani, Koji, Takamura, Shiki, Sakai, Hitomi, Kato, Ryoji, Takegawa, Naoki, Takahama, Takayuki, Tanaka, Kaoru, Hayashi, Hidetoshi, Takeda, Masayuki, Kato, Sigeki, Maenishi, Osamu, Sakai, Kazuko, Chiba, Yasutaka, Okabe, Takafumi, Kudo, Keita, Hasegawa, Yoshikazu, Kaneda, Hiroyasu, Yamato, Michiko, Hirotani, Kenji, Miyazawa, Masaaki, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Clinical cancer research (01.06.2018)

Get full text

Journal Article

The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine

The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine

by Hatanaka, Yutaka, Kuwata, Takeshi, Morii, Eiichi, Kanai, Yae, Ichikawa, Hitoshi, Kubo, Takashi, Hatanaka, Kanako C., Sakai, Kazuko, Nishio, Kazuto, Fujii, Satoshi, Okamoto, Wataru, Yoshino, Takayuki, Ochiai, Atsushi, Oda, Yoshinao
Published in Pathology international (01.11.2021)

Get full text

Journal Article

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

by Yonesaka, Kimio, Takegawa, Naoki, Watanabe, Satomi, Haratani, Koji, Kawakami, Hisato, Sakai, Kazuko, Chiba, Yasutaka, Maeda, Naoyuki, Kagari, Takashi, Hirotani, Kenji, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Oncogene (01.02.2019)

Get full text

Journal Article

Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer

Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer

by Watanabe, Satomi, Hayashi, Hidetoshi, Haratani, Koji, Shimizu, Shigeki, Tanizaki, Junko, Sakai, Kazuko, Kawakami, Hisato, Yonesaka, Kimio, Tsurutani, Junji, Togashi, Yosuke, Nishio, Kazuto, Ito, Akihiko, Nakagawa, Kazuhiko
Published in Cancer science (01.01.2019)

Get full text

Journal Article

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts

by Kato, Ryoji, Haratani, Koji, Hayashi, Hidetoshi, Sakai, Kazuko, Sakai, Hitomi, Kawakami, Hisato, Tanaka, Kaoru, Takeda, Masayuki, Yonesaka, Kimio, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in British journal of cancer (02.03.2021)

Get full text

Journal Article

Review of Cognitive Characteristics of Autism Spectrum Disorder Using Performance on Six Subtests on Four Versions of the Wechsler Intelligence Scale for Children

Review of Cognitive Characteristics of Autism Spectrum Disorder Using Performance on Six Subtests on Four Versions of the Wechsler Intelligence Scale for Children

by Takayanagi, Mizuho, Kawasaki, Yoko, Shinomiya, Mieko, Hiroshi, Hoshino, Okada, Satoshi, Ino, Tamiko, Sakai, Kazuko, Murakami, Kimiko, Ishida, Rie, Mizuno, Kaoru, Niwa, Shin-Ichi
Published in Journal of autism and developmental disorders (01.01.2022)

Get full text

Journal Article

HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer

HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer

by Yonesaka, Kimio, Tanizaki, Junko, Maenishi, Osamu, Haratani, Koji, Kawakami, Hisato, Tanaka, Kaoru, Hayashi, Hidetoshi, Sakai, Kazuko, Chiba, Yasutaka, Tsuya, Asuka, Goto, Hiroki, Otsuka, Eri, Okida, Hiroaki, Kobayashi, Maki, Yoshimoto, Ryoto, Funabashi, Masanori, Hashimoto, Yuuri, Hirotani, Kenji, Kagari, Takashi, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Clinical cancer research (15.01.2022)

Get full text

Journal Article

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

by Kimura, Hideharu, Sakai, Kazuko, Arao, Tokuzo, Shimoyama, Tatsu, Tamura, Tomohide, Nishio, Kazuto
Published in Cancer science (01.08.2007)

Get full text

Journal Article

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G

by Shitara, Kohei, Yonesaka, Kimio, Denda, Tadamichi, Yamazaki, Kentaro, Moriwaki, Toshikazu, Tsuda, Masahiro, Takano, Toshimi, Okuda, Hiroyuki, Nishina, Tomohiro, Sakai, Kazuko, Nishio, Kazuto, Tokunaga, Shoji, Yamanaka, Takeharu, Boku, Narikazu, Hyodo, Ichinosuke, Muro, Kei
Published in Cancer science (01.12.2016)

Get full text

Journal Article

Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing

Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing

by Iwahashi, Naoyuki, Sakai, Kazuko, Noguchi, Tomoko, Yahata, Tamaki, Matsukawa, Hitomi, Toujima, Saori, Nishio, Kazuto, Ino, Kazuhiko
Published in Scientific reports (18.07.2019)

Get full text

Journal Article

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

by Banno, Eri, Togashi, Yosuke, Nakamura, Yu, Chiba, Masato, Kobayashi, Yoshihisa, Hayashi, Hidetoshi, Terashima, Masato, Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Mitsudomi, Tetsuya, Nishio, Kazuto
Published in Cancer science (01.08.2016)

Get full text

Journal Article

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma

by Murakami, Kosuke, Kanto, Akiko, Sakai, Kazuko, Miyagawa, Chiho, Takaya, Hisamitsu, Nakai, Hidekatsu, Kotani, Yasushi, Nishio, Kazuto, Matsumura, Noriomi
Published in Modern pathology (01.11.2021)

Get full text

Journal Article

Correction to: Review of Cognitive Characteristics of Autism Spectrum Disorder Using Performance on Six Subtests on Four Versions of the Wechsler Intelligence Scale for Children

Correction to: Review of Cognitive Characteristics of Autism Spectrum Disorder Using Performance on Six Subtests on Four Versions of the Wechsler Intelligence Scale for Children

by Takayanagi, Mizuho, Kawasaki, Yoko, Shinomiya, Mieko, Hiroshi, Hoshino, Okada, Satoshi, Ino, Tamiko, Sakai, Kazuko, Murakami, Kimiko, Ishida, Rie, Mizuno, Kaoru, Niwa, Shin-Ichi
Published in Journal of autism and developmental disorders (2022)

Get full text

Journal Article

Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK―Positive Non―Small Cell Lung Cancer

Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK―Positive Non―Small Cell Lung Cancer

by TANIZAKI, Junko, OKAMOTO, Isamu, HATASHITA, Erina, NISHIO, Kazuto, NAKAGAWA, Kazuhiko, OKABE, Takafumi, SAKAI, Kazuko, TANAKA, Kaoru, HAYASHI, Hidetoshi, KANEDA, Hiroyasu, TAKEZAWA, Ken, KUWATA, Kiyoko, YAMAGUCHI, Haruka
Published in Clinical cancer research (15.11.2012)

Get full text

Journal Article

Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib

Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib

by Ishii, Hidenobu, Azuma, Koichi, Sakai, Kazuko, Naito, Yoshiko, Matsuo, Norikazu, Tokito, Takaaki, Yamada, Kazuhiko, Hoshino, Tomoaki, Nishio, Kazuto
Published in Scientific reports (20.01.2020)

Get full text

Journal Article

Performance of Oncomine Fusion Transcript kit for formalin‐fixed, paraffin‐embedded lung cancer specimens

Performance of Oncomine Fusion Transcript kit for formalin‐fixed, paraffin‐embedded lung cancer specimens

by Sakai, Kazuko, Ohira, Tatsuo, Matsubayashi, Jun, Yoneshige, Azusa, Ito, Akihiko, Mitsudomi, Tetsuya, Nagao, Toshitaka, Iwamatsu, Emi, Katayama, Jin, Ikeda, Norihiko, Nishio, Kazuto
Published in Cancer science (01.06.2019)

Get full text

Journal Article

$Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer$

Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer

by Shimizu, Toshio, Nishio, Kazuto, Sakai, Kazuko, Okamoto, Isamu, Okamoto, Kunio, Takeda, Masayuki, Morishita, Maiko, Nakagawa, Kazuhiko
Published in Cancer chemotherapy and pharmacology (01.08.2020)

Get full text

Journal Article

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

by Sakai, Hitomi, Tsurutani, Junji, Iwasa, Tsutomu, Komoike, Yoshifumi, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Breast cancer (Tokyo, Japan) (01.09.2018)

Get full text

Journal Article

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing

by Iwama, Eiji, Sakai, Kazuko, Azuma, Koichi, Harada, Daijiro, Nosaki, Kaname, Hotta, Katsuyuki, Nishio, Makoto, Kurata, Takayasu, Fukuhara, Tatsuro, Akamatsu, Hiroaki, Goto, Koichi, Shimose, Takayuki, Kishimoto, Junji, Nakanishi, Yoichi, Nishio, Kazuto, Okamoto, Isamu
Published in Cancer science (01.12.2018)

Get full text

Journal Article

Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

by Ohira, Tatsuo, Sakai, Kazuko, Matsubayashi, Jun, Kajiwara, Naohiro, Kakihana, Masatoshi, Hagiwara, Masaru, Hibi, Masaaki, Yoshida, Koichi, Maeda, Junichi, Ohtani, Keishi, Nagao, Toshitaka, Nishio, Kazuto, Ikeda, Norihiko
Published in Cancer science (01.11.2016)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[19]